###### Strengths and limitations of this study

-   To our knowledge, this is the most comprehensive systematic review and meta-analysis of contemporary exercise-based cardiac rehabilitation for people with all manifestations of coronary artery disease.

-   We conducted meta-analyses for 15 short-term and 9 medium-term outcomes.

-   We assessed risk of bias for all included studies using the Cochrane risk of bias tool.

-   Data had a high level of statistical heterogeneity and the majority of studies were identified as having 'some concerns' or 'high risk' in relation to the risk of bias assessment.

-   Data were insufficient to analyse at distinct time-points, thus were pooled as short-term (1--6 months) or medium term (8--12 months).

Introduction {#s1}
============

Coronary artery disease (CAD) is the leading cause of death worldwide.[@R1] Over the past 30 years, advances in interventional and secondary preventative cardiology have dramatically improved survival for people with CAD.[@R2] In high-income countries, living with CAD, as a long-term condition, is now common. Of the 200 000 people who have a myocardial infarction annually in the UK, 7 out of 10 survive. In 2018, there were over 900 000 survivors of myocardial infarction and 2.3 million people living with CAD in the UK.[@R4] This longevity after myocardial infarction represents a substantial and increasing burden on healthcare resource. There is a need for medical and lifestyle interventions that improve quality of life (QoL), maintain physical and psychosocial independence, and reduce long-term health and social care utilisation.

Cardiac rehabilitation (CR) has long been considered integral to the management of CAD.[@R5] Exercise training in conjunction with cardiovascular risk factor management, psychosocial support and behaviour change ('comprehensive' CR) are the core components of a complex health and lifestyle intervention, which is unreservedly advocated in international guidelines and policy.[@R6] Multiple meta-analyses incorporating trials spanning 1975--2018 reported favourable effects on functional capacity, hospital readmissions and mortality.[@R8]

Nevertheless, our 2018 systematic review (22 randomised controlled trials (RCTs), N=4834), which only included RCTs of 'contemporary' exercise-based CR that recruited after the end of 1999, found that the CR programmes tested had no effect on all-cause mortality (risk difference 0.0, 95% CI −0.02 to 0.01), and only a small effect on hospital readmissions of borderline statistical significance.[@R13] A 2018 network meta-analysis, while showing a reduction in mortality when including studies from 1975 to present day, found a non-significant reduction in mortality for studies published after 2001.[@R12] Existing data do not support the continued delivery of exercise-based CR in its current form where the intention is to reduce mortality or prevent hospital readmissions in CAD. For the continued use of these programmes to be justified for people with CAD, a paradigm shift in their stated aims is required.

In an ageing, multimorbid population, QoL, defined by WHO as 'an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns',[@R14] is a key priority for patients and healthcare providers. Patient-reported outcomes such as QoL are unique in providing the patient's perspective on the efficacy of medical or lifestyle interventions.[@R15] Furthermore, any change is tangible and subjective, thus patients can themselves perceive and report any benefit associated with CR. Therefore, CR should perhaps be judged on its ability to add 'life to years' rather than 'years to life'. Nearly all previous systematic reviews have considered QoL data for exercise-based CR to be insufficient or unsuitable for meta-analysis due to considerable heterogeneity in outcome measures and reporting. A 2016 Cochrane review[@R9] concluded that present data demonstrated improvement in at least one QoL domain in 65% of studies, and improvement in half or more of the reported domains in 25% of studies.

A 2018 meta-analysis (41 RCTs, N=11 747), pooling a range of measures and CR interventions from studies between 1975 and 2017, found that exercise training was associated with a small positive effect on QoL, but, overall, 'psychosocial management' was more effective.[@R16] A 2018 Cochrane review of exercise-based CR for angina pectoris was unable to draw conclusions on the impact of this intervention on QoL.[@R17] Subsequently, a 2019 meta-analysis reported exercise to be effective in reducing anxiety and depression following myocardial infarction.[@R18] However, in a review of prospective cohort studies,[@R19] people with depression were four times less likely to participate in CR and seven times more likely to drop out. A 2019 systematic review (14 RCTs, N=1739) of CR for people following acute coronary syndrome, published when this paper was being prepared for submission, included eight studies in a meta-analysis and concluded that there were clinically important positive effects on two 36-Item Short Form Survey Instrument (SF-36) domains at 6 months (role physical and general health) and one domain at 12 months (physical function).[@R20]

The objective of this systematic review and meta-analysis was to determine the effect of exercise-based CR on health-related QoL in all people with CAD, in the era of modern medical management.

Methods {#s2}
=======

The methodology for our systematic review and meta-analysis adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines and the study was registered on PROSPERO (CRD42018110197).

Search strategy and methodology {#s2-1}
-------------------------------

First, we reviewed all studies included in the most recent Cochrane systematic review of exercise-based CR in coronary heart disease.[@R9] Second, we assessed the 93 studies listed as *'excluded'* in the Cochrane review to identify any additional studies that met our inclusion criteria. Third, on 30 July 2019, we searched the Cochrane Central Register of Controlled Trials, MEDLINE (Ovid), Embase (Ovid) and CINAHL (EBSCO) databases using the strategy used in the Cochrane Systematic Review ([online supplementary appendix 1](#SP1){ref-type="supplementary-material"}).
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Results from our three predefined sources were individually examined to determine inclusion or exclusion. We retrieved abstracts, full-text manuscripts and supplementary material where necessary, and hand searched reference lists of the subsequently included articles (and other recent systematic reviews) to identify additional studies of interest. Two reviewers (GMcG and RP) independently undertook screening of the resultant citations, abstracts and manuscripts, with disputes mediated by a third reviewer (MU). Where data were missing or inappropriately presented, we requested additional information from lead and corresponding authors by email, on multiple occasions.

Study inclusion criteria {#s2-2}
------------------------

Our overall aim was to identify RCTs testing an exercise-based CR intervention against non-exercise usual care, with QoL as an outcome measure, which recruited after 31 December 1999. The rationale for excluding studies recruiting prior to the year 2000 is detailed elsewhere.[@R13] Briefly, we defined contemporary CR as postdating the widespread adoption of primary percutaneous coronary intervention and the 'modern' pharmacology outlined in the Joint British Society recommendations for the Prevention of Coronary Heart Disease in Clinical Practice.[@R21] Including studies that recruited after the end of 1999 allowed sufficient time for these innovations to become commonplace.

### Design {#s2-2-1}

We identified RCTs testing an exercise-based CR intervention against non-exercise usual care, which reported outcomes at any time-point following completion of the intervention. Previous reviews assessing mortality and hospitalisation have only included studies with at least 6 months follow-up.[@R9] For QoL indicators, we considered outcome measures at any time-point following completion of CR to be of interest. We excluded abstracts, conference proceedings, theses and non-English language publications.

### Participants {#s2-2-2}

We included all studies where participants either had CAD confirmed with coronary angiography, had a diagnosis of angina pectoris, had undergone coronary revascularisation via either percutaneous coronary intervention or coronary artery bypass grafting, or had sustained a myocardial infarction.

### Interventions {#s2-2-3}

We defined interventions as exercise-based CR undertaken with or without supervision as a hospital inpatient, as a hospital outpatient, in a community venue or at home. Furthermore, the exercise programme could have been delivered in isolation or in combination with other educational, behavioural or psychosocial components constituting a 'comprehensive' multicomponent CR programme. We defined usual care as any intervention delivered to people with CAD that did not include a structured exercise component, that is, disease-specific education, smoking cessation, dietary advice or psychosocial support, delivered without supervised exercise training. We excluded studies in which both groups had completed a CR exercise training intervention prior to randomisation to an exercise intervention or a non-exercise control.

### Outcome measures {#s2-2-4}

Data were extracted from studies reporting between-group difference in QoL, collected with a generic or cardiovascular disease-specific, validated measure, for example, the SF-36 at any time-point post-CR. Measures were considered to be validated if there was evidence in the peer-reviewed literature that the instrument had been psychometrically tested for reliability, validity and/or sensitivity.

### Data extraction and statistical analysis {#s2-2-5}

Any QoL data available at baseline and follow-up were extracted from studies that met the inclusion criteria. For each of the exercise-based CR and non-exercise usual care arms, the data extracted at each visit were the mean QoL score and the SD of the QoL score. If the means and SDs were not explicitly reported, they were extracted from line graphs (where possible) or derived from CIs. The SDs were computed assuming the CIs were obtained taking the point estimates to be normally distributed.

To pool the results from all studies for each QoL measure at a particular time-point, we fitted a random-effects meta-analysis model in the R statistical program.[@R22] The pooled results were summarised in forest plots. Where means and SDs in each arm were available for all included studies, the 'meta' package, with a command that requires specifying the mean and SD for each arm, was used to perform the meta-analysis.[@R23] For the short-term SF-36 Mental Health Component and Physical Health Component scores, two studies[@R24] reported the mean difference and the SE, thus it was not possible to extract the means and SDs. Therefore, the 'metafor' package, with a command that requires specifying mean difference and SE for each study, was used to perform the meta-analysis.[@R26] This was the same approach to extracting EuroQol-5D (EQ-5D) data in another study.[@R27] In these cases, if a study reported means and SDs, these were used to calculate the mean difference and the SE.

There were two options for defining the outcomes to be used to compare usual care and exercise-based CR at any particular time-point: (1) taking the outcome as the QoL score at each time-point or (2) taking the outcome as the change in QoL score from baseline. Some studies did not report baseline values or changes, and so the former definition was chosen. This enabled the inclusion of more studies in the meta-analyses.

### Assessment of risk of bias {#s2-2-6}

We performed a risk of bias assessment for all studies included in our meta-analyses using V.2 of the Cochrane risk of bias tool for randomised trials.[@R28] Accordingly, risk of bias was assessed for general trial procedures and specifically for the QoL outcome of interest. Each trial was assessed against five domains of bias: (1) bias arising from the randomisation process; (2) bias due to deviations from intended interventions; (3) bias due to missing outcome data; (4) bias in measurement of the outcome and (5) bias in selection of the reported result. As per the Cochrane Handbook,[@R28] an overall risk of bias score of 'low', 'some concerns' or 'high' was determined for each trial. 'Low' risk of bias was implied when all domains were scored 'low'. 'Some concerns' was implied when at least one domain was scored as 'some concerns'. 'High' risk of bias was implied when at least one domain was scored as 'high', or multiple domains were scored 'some concerns'. All studies were assessed independently by two reviewers (GMcG and RP) with discrepancies resolved by a third (MU).

Patient and public involvement {#s2-3}
------------------------------

There was no patient and public involvement in this systematic review.

Results {#s3}
=======

Studies retrieved {#s3-1}
-----------------

Thirteen studies in the Cochrane review[@R24] met our criteria and one study was identified from the Cochrane excluded studies list.[@R40] Of 32 studies retrieved for full evaluation from our updated literature search, 3 were excluded as they were not RCTs, 14 because they did not use QoL as an outcome measure, 3 because participants completed structured CR prior to being randomised to a CR intervention or control group and 2 because they did not qualify as 'exercise-based CR': this left 10 studies.[@R25] A total of 24 studies (N=4,890) were suitable for inclusion ([figure 1](#F1){ref-type="fig"}).

![Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram. CR, cardiac rehabilitation; QoL, quality of life; RCT, randomised controlled trial.](bmjopen-2019-036089f01){#F1}

All studies reported QoL using at least one validated measure, and seven studies used two measures. Six different generic measures were used: SF-36 (14 studies), 12-item Short Form Survey (SF-12, 2 studies), EQ-5D (2 studies) and 20-item Short Form Survey (SF-20), 15 D Questionnaire, Time Trade Off Questionnaire 1 study each. Six cardiac-specific measures were used: MacNew QoL Questionnaire (four studies), HeartQoL Questionnaire (two studies) and Duke Activity Status Index (DASI), the Seattle Angina Questionnaire, Quality of Life Index-cardiac version III and Myocardial Infarction Dimensional Assessment Scale all one study each.

Data were reported at varying time-points and presented in numerous statistical formats, thus reducing the number of point estimates we could reliably include in each analysis. We contacted authors from eight studies[@R24] to request provision of data in a format consistent with our meta-analysis protocol. A response was received from two authors stating that the data were not available.[@R37]

We performed meta-analyses at two time-points: short-term (immediately postintervention, or as soon as possible thereafter, up to 6 months (1--6 months)) and medium-term (8--12 months postrandomisation). This allowed us to assess both the immediate postintervention effect of exercise-based CR, and the long-term effect. Where data were reported twice within the short-term timescale (ie, 3 and 6 months),[@R35] data recorded closest to the end of the intervention period were included in the meta-analysis. We pooled data from studies using SF-36 and SF-12, henceforth SF-36. Data were sufficient to undertake meta-analysis for three measures: the SF-36 (eight domains and physical component score for the short-term and medium-term time-points, plus the physical component score for the short-term time-point only), the EQ-5D (short-term only) and the MacNew (short-term only).

Excluded studies and erroneous data {#s3-2}
-----------------------------------

Despite the SF-20 Questionnaire being broadly a derivative of the SF-36 and SF-12, we did not include one study[@R29] in the SF-36 analyses as the questions and scoring algorithms are not sufficiently comparable. One study[@R46] described exercise performed as an inpatient prior to randomisation. We included this study as the prerandomisation exercise involved gentle mobilisation only, as opposed to a structured CR exercise intervention, thus fitting with our inclusion criteria. For the same reasons, we excluded a study[@R50] in which both groups did complete a structured exercise-based CR intervention prior to randomisation. Following full-text retrieval, we excluded two studies[@R51] which, although aimed to increase participation in physical activity, employed general lifestyle interventions as opposed to exercise-based CR as defined in our protocol.

For one study,[@R41] only selected SF-36 variables were reported; physical function domain, and mental component score and physical component score. We were able to include the physical function domain data but were unable to include the mental and physical component score subscales data as the mean values reported were out of range for the measure. Data from another study[@R53] reporting the SF-36 could not be accurately extracted from a line-graph, and for another,[@R31] could not be meta-analysed, as the way in which the data were reported meant multiple assumptions would have been required. For the EQ-5D, we performed meta-analysis at the short-term time-point using data from two studies.[@R27] We could not include EQ-5D data from one study,[@R47] as all the information required for a meta-analysis was not reported. For another study,[@R49] mean values were out of the measurement range for the MacNew Questionnaire, thus, while otherwise the study met our inclusion criteria, the data could not be included. [Online supplementary appendix 2](#SP2){ref-type="supplementary-material"} shows how data were extracted and included in the meta-analyses where means or SDs were not explicitly reported.
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Sample size, gender, age and study origin {#s3-3}
-----------------------------------------

We included 4890 randomised participants in our analyses. Of the 24 studies, 21 included both male and female participants, 1 study included males only[@R33] and 1 study did not specify[@R43] the gender of participants recruited ([table 1](#T1){ref-type="table"}). The mean age of participants in each study was 62 years, range 53--77 years. One study reported an incorrect mean age.[@R49] Three studies were conducted in the UK,[@R36] 9 elsewhere in Europe[@R24] and 12 outside Europe.[@R27]

###### 

Characteristics of included studies and interventions

  Study                         Country        Recruitment period   N randomised                      Mean age (years)          Male participants (%)               Participant diagnosis                                                                                                                  Exercise intervention                                                                                                                                   Comparator (control)                                                                                                           Medication
  ----------------------------- -------------- -------------------- --------------------------------- ------------------------- ----------------------------------- -------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------
  Asbury *et al* [@R40]         UK             Not specified        42                                65                        83                                  Angina pectoris and/or previous history of single or multiple MI, CABG, PCI.                                                           Outpatient group-based circuit, home exercise programme and 8-week symptom monitoring diary.                                                            Standard treatment, 8-week symptom monitoring diary.                                                                           Full description and breakdown.
  Belardinelli *et al* [@R29]   Italy          Not specified        118                               57                        84                                  CAD, post-PCI or coronary stenting.                                                                                                    Outpatient group cycling.                                                                                                                               Recommendations to perform basic daily mild physical activities but avoid physical training.                                   Full description and breakdown, lipid-lowering drugs were not allowed.
  Bettencourt *et al* [@R30]    Portugal       2001--2002           126                               57                        84                                  Acute coronary syndrome (unstable angina or MI). Revascularisation procedure not specified.                                            Outpatient group treadmill or cycling.                                                                                                                  Standard cardiological follow-up.                                                                                              No description.
  Briffa *et al* [@R31]         Australia      Not specified        113                               61                        74                                  Uncomplicated acute myocardial infarction or unstable angina who underwent PCI or CABG or treated by thrombolytic therapy.             Outpatient group aerobic circuit training interspaced with resistance training.                                                                         Pharmacotherapy and lifestyle counselling.                                                                                     Full description and breakdown.
  Chen *et al* [@R41]           China          Not specified        44                                69                        78                                  CAD who underwent PCI or CABG.                                                                                                         Outpatient group cardiopulmonary exercise training, strength and balance training.                                                                      Medical management and clinic visits as needed.                                                                                Reference to beta-blocker but no other medication.
  Devi *et al* [@R42]           UK             2008--2010           94                                66                        75                                  Stable angina. Stents or CABG.                                                                                                         Web-based exercise intervention including individualised goal setting, exercise diary and feedback.                                                     Usual treatment from their GP.                                                                                                 Reference to medication but no breakdown.
  Firouzabadi *et al* [@R43]    Iran           Not specified        70                                59                        Not specified (similar in gender)   Cardiovascular patients after CABG.                                                                                                    Hospital-based group aerobic exercise.                                                                                                                  No intervention.                                                                                                               No description.
  Hassan and Nahas[@R48]        Egypt          Not specified        60                                53                        68                                  After PCI.                                                                                                                             Hospital-based aerobic exercise training.                                                                                                               Instruction about risk factors after PCI.                                                                                      Reference to medication but no breakdown.
  Hautala *et al* [@R44]        Finland        2011--2014           204                               61                        72                                  Patients with CAD who suffered from acute coronary syndrome with PCI or CABG.                                                          Outpatient gym-based group and home-based aerobic exercise training, strength training and exercise diary.                                              No individualised tailored exercise prescriptions.                                                                             Full description and breakdown.
  Højskov *et al* [@R45]        Denmark        Not specified        60                                65                        78                                  Elective CABG.                                                                                                                         Hospital-based, two groups including exercise:Physical exercise plus usual care.Physical exercise and psychoeducation plus usual care.                  Two groups of no exercise:Psychoeducational intervention plus usual care.Usual care alone.                                     Full description and breakdown.
  Højskov *et al* [@R25]        Denmark        Not specified        326                               65                        86                                  Elective CABG.                                                                                                                         Hospital-based, physical exercise plus usual care and exercise diary.                                                                                   Usual care procedures, which included medical follow-up and standard.                                                          Full description and breakdown.
  Houle *et al* [@R32]          Canada         2007--2008           65                                59                        79                                  Unstable angina, non-ST-elevation or ST-elevation myocardial infarction with PCI or CABG.                                              Home-based pedometer-based programme                                                                                                                    Usual advice regarding physical activity, diet and medication.                                                                 Reference to medication for control group but no breakdown.
  Maddison *et al* [@R27]       New Zealand    2011--2012           171                               60                        81                                  Angina, MI, revascularisation including angioplasty, stent or CABG.                                                                    Home-based moderate to vigorous personalised exercise programme, automated text messages to increase exercise behaviour, technical support.             Free to participate in any other CR service or support that they wished to.                                                    No description.
  Mutwalli *et al* [@R33]       Saudi Arabia   2008--2010           49                                57                        100                                 Following CABG.                                                                                                                        In-patient and home-based walking programme.                                                                                                            Usual hospital care and advice.                                                                                                Reference to medication but no breakdown.
  Oerkild *et al* [@R24]        Denmark        2007--2008           40                                77                        58                                  MI, PCI, CABG.                                                                                                                         Home-based walking programme.                                                                                                                           Risk factor intervention and medical adjustment.                                                                               Full description and breakdown.
  Peixoto *et al* [@R46]        Brazil         2010--2013           100                               56                        70                                  MI and PCI with or without chemical reperfusion therapy.                                                                               Inpatient early mobilisation exercise programme and outpatient walking programme.                                                                       Education regarding physical activity, diet and medication.                                                                    Full description and breakdown.
  Reid *et al* [@R39]           Canada         2004--2007           223                               56                        84                                  Acute coronary syndrome, post-PCI.                                                                                                     Home-based, web-based 'CardioFit' programme including physical activity plan, expert advice and motivational feedback.                                  Physical activity guidance and education booklet.                                                                              Full description and breakdown in supplemental table.
  Salavati *et al* [@R49]       Iran           2013                 110                               Specified but incorrect   Specified but incorrect             Post-CABG.                                                                                                                             Home-based walking programme, including home visits and telephone calls.                                                                                Usual education.                                                                                                               Reference to medication for intervention group but no breakdown.
  Sandström and Ståhle[@R34]    Sweden         Not specified        101                               71                        80                                  Acute coronary event. Number of patients with previous PCI or CABG.                                                                    Outpatient group aerobic training programme.                                                                                                            Information meetings about disease, importance and recommendations of physical activity and pharmacological therapy.           No description.
  Santaularia *et al* [@R47]    Spain          2010--2012           86                                60                        85                                  MI, pre-infarct angina, angina pectoris, specific or unspecified ischaemic heart disease. Revascularisation procedure not specified.   Outpatient exercise training programme.                                                                                                                 Standard hospital care, oral and written information on risk factors, advice and guidance on returning to physical activity.   Reference to medication but no breakdown.
  Wang *et al* [@R35]           China          2005--2007           160                               58                        83                                  MI and PCI.                                                                                                                            Home-based rehabilitation programme using a self-help manual.                                                                                           Encouragement and general advice on self-management.                                                                           Full description and breakdown.
  West *et al* [@R36]           UK             1997--2000           1813                              64                        74                                  MI\. Number of patients with previous PCI or CABG.                                                                                     Outpatient comprehensive exercise-based cardiac rehabilitation as delivered in the UK.                                                                  Usual care including access to booklets and routine outpatient follow-up.                                                      Full description and breakdown.
  Yu *et al* [@R37]             Hong Kong      Not specified        269                               64                        76                                  MI, PCI performed for angina pectoris.                                                                                                 Four phases:Inpatient ambulatory programme.Outpatient aerobic exercise training.Community-based home exercise programme.Long-term maintenance period.   Cardiac clinic, conventional therapy, risk factor education.                                                                   Full description and breakdown.
  Zwisler *et al* [@R38]        Denmark        2000--2003           770 (446 with diagnosis of IHD)   66                        64                                  MI, angina pectoris, PCI, CABG.                                                                                                        Hospital-based intensive cardiac rehabilitation programme.                                                                                              Usual care and pharmaceutical treatment.                                                                                       Full description and breakdown.

CABG, coronary artery bypass graft; CAD, coronary artery disease; IHD, ischaemic heart disease; MI, myocardial infarction; PCI, percutaneous coronary intervention.

Participant diagnosis of coronary artery disease {#s3-4}
------------------------------------------------

Participant diagnoses, that is, manifestations of CAD, was described in all studies ([table 1](#T1){ref-type="table"}). Fourteen trials included participants with a range of diagnoses including CAD confirmed with coronary angiography, angina pectoris, myocardial infarction, percutaneous coronary intervention and/or coronary artery bypass grafting.[@R27] Four studies included participants following myocardial infarction only,[@R24] and one study, angina pectoris only.[@R42] Five studies recruited participants 'following coronary artery bypass grafting'[@R25] and one study 'after percutaneous coronary intervention'.[@R48]

Treatment received {#s3-5}
------------------

Twelve studies included participants who had been revascularised by percutaneous coronary intervention or coronary artery bypass grafting following a recent or past cardiac event[@R24] ([table 1](#T1){ref-type="table"}). Five studies recruited participants following percutaneous coronary intervention only[@R29] and five studies recruited participants following coronary artery bypass grafting only.[@R25] It was unclear in two studies whether participants had been revascularised before randomisation and, if so, by which specific procedure.[@R30]

Medication {#s3-6}
----------

Thirteen studies provided a full description of medication ([table 1](#T1){ref-type="table"}). Six studies referred to medication but provided no specific detail.[@R32] One study reported beta-blocker usage without reference to other medications.[@R41] The remaining four studies did not provide any information about medication.[@R27]

Recruitment period {#s3-7}
------------------

Thirteen studies recruited participants after 31 December 1999 ([table 1](#T1){ref-type="table"}). In one study, participants were recruited between 1997 and 2000.[@R36] On the basis that participant diagnosis, treatment received and co-existing medical therapies indicated 'contemporary' medical care, it was agreed by all reviewers to include this study. This is consistent with the approach used in our previous review of survival.[@R13] For the remaining 10 studies, a recruitment period could not be clearly determined from the manuscripts. However, given the description of participant diagnosis, medical treatment, pharmacological therapies and CR interventions, it was agreed by all reviewers that they met our criteria for inclusion.

Content of the interventions {#s3-8}
----------------------------

Intervention content varied considerably between studies ([tables 1 and 2](#T1 T2){ref-type="table"}). Nineteen studies compared exercise training in combination with additional therapies (education and psychosocial components), two studies compared exercise training as a stand-alone intervention,[@R29] while one study combined exercise and relaxation.[@R43] The exercise components of the interventions varied with respect to the setting, training modality, duration, session length, frequency and intensity. The majority of studies incorporated walking and/or cycling as the main exercise modality, delivered for a period ranging from 4 to 12 months, in either an inpatient, home-based or out-patient setting.

###### 

Intervention components of included studies

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                         Exercise type\                                                Intervention duration                                Session frequency (per week)           Session time                                                                               Session intensity                                                                                                  Supervised/Non-supervised (exercise provider)                                                                Additional components                                                                                    Fidelity to exercise intervention described
                                (modality)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  ----------------------------- ------------------------------------------------------------- ---------------------------------------------------- -------------------------------------- ------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------
  Asbury *et al* [@R40]         Circuit of cardiovascular and rest stations                   8 weeks                                              Not specified                          80 min                                                                                     60%--75% of HRR (normal LV) or 40%--60% HRR (LV\<40%).                                                             Not specified.                                                                                               Health promotion seminars.                                                                               Not specified.

  Belardinelli *et al* [@R29]   Cycling                                                       6 months                                             3                                      53 min                                                                                     60% of peak oxygen uptake.                                                                                         Supervised (cardiologist).                                                                                   Not specified.                                                                                           Not specified.

  Bettencourt *et al* [@R30]    Cycling or treadmill                                          12 weeks                                             3                                      20--30 min                                                                                 Based on maximum HR reached on exercise test prior.                                                                Supervised (under qualified supervision).                                                                    Standard cardiological follow-up. One session a month for 12 months.                                     Not specified.

  Briffa *et al* [@R31]         Circuit (aerobic/resistance)                                  6 weeks                                              3                                      60--90 min                                                                                 Not specified.                                                                                                     Supervised (treating doctor).                                                                                Education on lifestyle and risk factor management.                                                       23 (40%) completed 75% or more of all sessions offered.

  Chen *et al* [@R41]           Cycling                                                       12 weeks                                             3                                      50 min                                                                                     60%--80% of HRR.                                                                                                   Supervised (physician and a physical therapist).                                                             Resistance and balance training.                                                                         Not specified.

  Devi *et al* [@R42]           Physical exercise, most commonly walking                      6 weeks                                              Daily                                  Advice to be physically active for 30 min five times a week                                Not specified.                                                                                                     Unsupervised.                                                                                                Information about secondary prevention and education on lifestyle and risk factor management.            Compliance assessed by exercise diaries, questionnaires and electronic feedback on performance.

  Firouzabadi *et al* [@R43]    Cycling and treadmills                                        8--10 weeks                                          3                                      60--90 min                                                                                 Not specified.                                                                                                     Supervised (medical and CCU nurses.                                                                          Relaxation.                                                                                              Not specified.

  Hassan and Nahas[@R48]        Cycling                                                       6 months                                             3                                      50 min                                                                                     Mild-to-moderate intensity based on Borg's RPE scale.                                                              Not specified.                                                                                               Education on lifestyle and risk factor management.                                                       Not specified.

  Hautala *et al* [@R44]        Walking, running, cycling, cross-country skiing               1 year\                                              4--5                                   30--45 min strength (gym-based), 30--40 min aerobic and 30--40 min strength (home-based)   12--15 Borg's RPE.                                                                                                 Supervised (in the gym by a physical therapist). Unsupervised at home.                                       Accelerometry, strength exercise, dietary counselling or a check-up by a medical doctor.                 Use of exercise diaries to prescribe target duration/intensity and record trained mode, duration and mean RPE.
                                                                                              (6 months gym and home-based, 6 months home-based)                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Højskov *et al* [@R45]        Walking, cycling                                              4 weeks                                              Walking: daily\                        Walking: not specified\                                                                    13--15 on Borg's RPE.                                                                                              Supervised (physiotherapist).                                                                                Deep breathing exercises. Muscle and endurance exercises.\                                               Acceptability, adherence and attrition to the intervention and study was measured and reported. Safety and tolerability also reported.
                                                                                                                                                   Cycling: twice daily                   Cycling: 2×10 min.                                                                                                                                                                                                                                                                                                         Psychoeducation and mindfulness.                                                                         

  Højskov *et al* [@R25]        Walking, cycling                                              4 weeks                                              Walking: twice daily then 3× daily.\   Walking: 2×5 min to 3×10 min.\                                                             Walking: low-to-moderate.\                                                                                         Supervised (physiotherapist).                                                                                Respiratory physiotherapy, neck and shoulder exercises.\                                                 Intervention adherence was defined as completing at least 75% of exercise sessions.
                                                                                                                                                   Cycling: daily then twice daily.       Cycling: 2×10 min.                                                                         Cycling:13--15 on Borg's RPE.                                                                                                                                                                                                   Psychoeducation and mindfulness.                                                                         

  Houle *et al* [@R32]          Walking                                                       12 months                                            Daily                                  Not specified                                                                              Not specified.                                                                                                     Unsupervised.                                                                                                Socio-cognitive intervention. Access to exercise specialist, nutritionist, psychologist and physician.   Monitoring through a pedometer and exercise diary.

  Maddison *et al* [@R27]       Physical exercise, in particular walking                      24 weeks                                             At least 5                             Minimum 30 min                                                                             Moderate-to-vigorous aerobic-based exercise (11--13 on Borg's RPE in early stages then 13--15 in latter stages).   Not specified.                                                                                               Behavioural change strategies and technical support.                                                     Self-reported physical activity.

  Mutwalli *et al* [@R33]       Walking                                                       6 months                                             7                                      30 min                                                                                     Not specified.                                                                                                     Supervised on ward then unsupervised at home.                                                                Talks and workshops on lifestyle and risk factor management.                                             Not specified.

  Oerkild *et al* [@R24]        Individualised                                                12 months                                            6                                      30 min                                                                                     13--15 on Borg's RPE.                                                                                              Unsupervised.                                                                                                Consultations with cardiologist. Dietary counselling and smoking cessation (if required).                Self-reported physical activity.

  Peixoto *et al* [@R46]        Walking                                                       1 month                                              4                                      30--50 min                                                                                 4 and 5 on RPE scale rating.                                                                                       Unsupervised.                                                                                                Education on lifestyle and risk factor management.                                                       Not specified.

  Reid *et al* [@R39]           Personally tailored physical activity plan.                   20 weeks                                             Not specified                          Not specified                                                                              Not specified.                                                                                                     Unsupervised.                                                                                                Psychological support.                                                                                   Monitoring through pedometer. Self-reported physical activity. Reference to online tutorials completed and email correspondence.

  Salavati *et al* [@R49]       Not specified                                                 5 weeks                                              4                                      Not specified                                                                              Not specified.                                                                                                     Unsupervised.                                                                                                Education on lifestyle and risk factor management.                                                       Not specified.

  Sandström and Ståhle[@R34]    Not specified                                                 3 months                                             3                                      50 min                                                                                     Not specified.                                                                                                     Supervised (specialist physiotherapist).                                                                     Relaxation sessions. Education on lifestyle and risk factor management.                                  Not specified.

  Santaularia *et al* [@R47]    Cycling                                                       10 weeks                                             3                                      60 min                                                                                     75%--90% of max HR (11--15 on Borg's RPE.                                                                          Supervised (physiotherapist).                                                                                Resistance training, education on lifestyle and risk factor management.                                  Intensity measured using a pulse oximeter.

  Wang *et al* [@R35]           Not specified                                                 6 weeks                                              Not specified                          Not specified                                                                              Not specified.                                                                                                     Unsupervised.                                                                                                Health education.                                                                                        Not specified.

  West *et al* [@R36]           Varied by centre (exercise equipment in physiotherapy gyms)   6--8 weeks                                           1--2                                   Average 20 hours over intervention duration                                                Not specified.                                                                                                     Supervised (nurse, occupational therapists or physiotherapists plus one other Allied Health Professional).   Education on lifestyle and risk factor management.                                                       Not specified.

  Yu *et al* [@R37]             Treadmill, cycling, rowing, stepper, arm ergometry            8 weeks (phase II)                                   2                                      2 hours                                                                                    65%--85% of maximal aerobic capacity.                                                                              Supervised (physiotherapist and occupational therapist).                                                     Resistance training, education on lifestyle and risk factor management.                                  Not specified.

  Zwisler *et al* [@R38]        Not specified                                                 6 weeks                                              2                                      Not specified                                                                              Not specified.                                                                                                     Supervised (multidisciplinary team).                                                                         Psychosocial support, education on lifestyle and risk factor management.                                 Not specified.
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CCU, coronary care unit; HR, heart rate; HRR, heart rate reserve; LV, left ventricular; RPE, rating or perceived exertion.

Overall effects of interventions {#s3-9}
--------------------------------

### SF-36 short-term {#s3-9-1}

We included data from four trials (N= 560) for six SF-36 domains[@R27] and data from five trials for the physical function[@R27] and bodily pain[@R27] domains (N= 596 and 600) in our meta-analyses ([figure 2A](#F2){ref-type="fig"}). The data were heterogeneous (I[@R2] \>80% for seven of eight domains). Point estimates favoured exercise-based CR in all domains. In six domains, physical function (12.0 (95% CI 4.4 to 19.6)), role physical (16.9 (2.4 to 31.3)), general health (4.6 (1.9 to 7.2)), vitality (7.6 (1.2 to 14.0)), social function (10.9 (2.0 to 19.8)) and mental health (4.4 (0.3 to 8.6)), these differences were statistically significant.

![(A) Meta-analysis for quality of life (36-Item Short Form Survey Instrument (SF-36) domains) at the short-term time-point. (B) Meta-analyses of SF-36 aggregate scores (MCS, mental component score; PCS, physical component score and total) at the short-term time-point.](bmjopen-2019-036089f02){#F2}

We included data from three trials (N=371)[@R24] that reported the physical and mental component scores of the SF-36. No statistical significant differences were found ([figure 2B](#F2){ref-type="fig"}). We meta-analysed data from two studies (N=112)[@R33] reporting an overall SF-36 score. A statistically significant benefit (24.9 (95% CI 16.7 to 33.2)) was found.

### SF-36 medium-term {#s3-9-2}

In our meta-analyses, we included data from three trials (N= 1870)[@R36] for six SF-36 domains, and data from four trials (N=1996)[@R30] for the general health and vitality domains. The data were less heterogeneous than the short-term data (I[@R2] \>80% for three of eight domains). Point estimates favoured exercise-based CR in all domains. In five domains, physical function (4.0 (95% CI 0.7 to 7.3)), role physical (6.9 (0.2 to 13.6)), general health (6.0 (0.9 to 11.1)), vitality (6.5 (0.6 to 12.3)) and social function (6.2 (0.9 to 11.4)), these differences were statistically significant ([figure 3A](#F3){ref-type="fig"}).

![(A) Meta-analysis for quality of life (36-Item Short Form Survey Instrument (SF-36) domains) at the medium-term time-point. (B) Meta-analyses of SF-36 aggregate scores (MCS and PCS) at the medium-term time-point.](bmjopen-2019-036089f03){#F3}

We included data from two trials (N=478)[@R30] that reported the mental component score of the SF-36, one of which also reported the physical component score (N = 372).[@R38] No statistically significant differences were found ([figure 3B](#F3){ref-type="fig"}).

### EuroQol-5D {#s3-9-3}

We included data from two studies that reported short-term outcomes for the EQ-5D (N=254).[@R27] The point estimate favoured exercise-based CR but was not statistically significant ([figure 4A](#F4){ref-type="fig"}). No studies reported medium-term outcomes for the EQ-5D.

![(A) Meta-analysis for EuroQol-5D (EQ-5D) at the short-term time-point. (B) Meta-analysis for quality of life (MacNew) at the short-term time-point.](bmjopen-2019-036089f04){#F4}

### MacNew Questionnaire {#s3-9-4}

We included data from three studies that reported short-term outcomes for the MacNew subscales (N=316, 316 and 318).[@R39] Two of these also reported an overall score (N=242).[@R39] All point estimates favoured exercise-based CR but there were no statistically significant differences ([figure 4B](#F4){ref-type="fig"}).

### Other measures {#s3-9-5}

Eight other QoL measures were each reported by one study. Statistically significant benefits were found in seven out of eight domains of the MOS (Medical Outcomes Study 20-Item Short Form Survey) 20 at 12 months, the EQ-5D mobility subscale at 12 months, the DASI at 4 and 12 months, the Seattle Angina Questionnaire emotional score at 6 weeks, the overall Quality of Life Index-cardiac version III and the same five out of seven of MIDAS subscales at 3 and 12 months ([online supplementary appendix 3](#SP3){ref-type="supplementary-material"}).
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Risk of bias assessment {#s3-10}
-----------------------

We assessed two of the studies included in our meta-analyses as having a low risk of bias (N=463),[@R25] nine as having 'some concerns' (N=2493)[@R24] and the remaining seven as high risk (N=671)[@R30] ([online supplementary appendix 4](#SP4){ref-type="supplementary-material"}, [figure 5](#F5){ref-type="fig"}). Methodological issues leading to a classification of high risk of bias related primarily to two domains: (1) deviations from the intended interventions and (2) missing outcome data. For the former, lack of intention-to-treat analysis and inadequate blinding were common issues. For the latter, high loss to follow-up was a common issue.

10.1136/bmjopen-2019-036089.supp4

![Risk of bias assessment. Does exercise-based cardiac rehabilitation improve quality of life in coronary artery disease? A contemporary systematic review and meta-analysis.](bmjopen-2019-036089f05){#F5}

Discussion {#s4}
==========

We performed meta-analyses of 15 short-term and 9 medium-term outcomes. With such a large number of comparisons, some statistically significant findings could be expected due to random chance. Two-thirds of the analyses (16/24) were for the eight SF-36 domains. Multiple individual SF-36 domain scores showed statistically significant positive results from exercise-based CR, both in the short-term and medium-term. However, the domains in which a statistically significant effect was observed were different for the short-term and medium-term outcomes. These findings should be interpreted with considerable caution; the quality of the included trials was generally poor and there was substantial statistical heterogeneity. Nevertheless, the overall picture for all domains at both time points favours exercise-based CR, suggesting that there may be an overall benefit on SF-36 domain scores.

The meta-analyses of the SF-36 physical and mental component scores at 12 months, in contrast, did not show any benefit from exercise-based CR. We have for completeness included a meta-analysis of an overall SF-36 score showing a clear benefit from exercise-based CR. The SF-36 overall score is not an accepted metric.[@R54] While these studies met our inclusion criteria, we attach very little weight to this finding because of the non-standard approach to the analysis of the SF-36.

The meta-analysis for the MacNew Questionnaire, a cardiovascular disease-specific outcome, did not find any statistically significant short-term benefit. Nevertheless, for all three domains, the direction of change favoured exercise-based CR. We found no data on the medium-term or long-term benefits of exercise-based CR on cardiovascular disease-specific QoL. Similarly, the meta-analysis of EQ-5D data found a non-significant difference in favour of exercise-based CR.

A broadly similar pattern was seen in the trials not suitable for meta-analysis, with some statistically significant findings on certain outcomes but with no consistent support for benefit. Taking all of these data into account, our interpretation is that there is some evidence of a beneficial effect of exercise-based CR on QoL in the short-term and insufficient data to comment on the medium-term or long-term benefits. In combination, therefore, undertaking an exercise programme, risk factor modification and behavioural education as part of a comprehensive CR programme may have some impact on individual domains of health-related QoL.

Our observations are limited by the quality of the included studies and the heterogeneity of both the trial participants and the interventions tested. We cannot exclude the possibility that there are subgroups for whom exercise-based CR is effective. To contextualise this observation, data from our previous review of mortality[@R13] in exercise-based CR should be considered (mortality was not assessed in the current review). The review was criticised for not considering the potentially greater benefit for those who adhere to treatment.[@R56] Since the overall effect on mortality in our previous review was zero, any reduced mortality in the subgroup that adhered, would inevitably mean an equal increase in mortality in participants who did not adhere. In contrast, given the positive effect of exercise-based CR on QoL in the current analyses, it is plausible that poor adherence to the intervention is attenuating the benefits. If there is a zero effect in those who do not adhere, there may be a worthwhile effect in those who do adhere. None of our included studies presented an analysis that would allow the effect size in adherent participants to be estimated appropriately.[@R57] The approach of comparing outcomes in the adherent group with overall outcomes in the control group used by some authors[@R25] is potentially misleading. An appropriate approach, such as a complier average causal effect analysis, would adjust for non-compliance, thus providing more reliable results.

Our previous review[@R13] has been criticised for including the RAMIT (Rehabilitation After Myocardial Infarction Trial) trial.[@R36] Other recent reviews[@R20] using the same recruitment period criteria as us, excluded the RAMIT trial whose recruitment straddled the end of 1999. In a post hoc sensitivity analysis we excluded RAMIT data. It did not materially affect our conclusions ([online supplementary appendix 5](#SP5){ref-type="supplementary-material"}). For completeness, we also provide our previous mortality analysis with RAMIT excluded ([online supplementary appendix 6](#SP6){ref-type="supplementary-material"}). Again, this does not materially change our previous conclusions.

10.1136/bmjopen-2019-036089.supp5
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Post hoc, to inform a discussion on the clinical relevance of our findings, we searched unsuccessfully for established values of clinically important between-group differences, following CR, for the outcomes included in our meta-analyses. For the SF-36, the minimal clinically important within-person change has been reported as an increase in any domain score of three to five points.[@R58] All of our statistically significant differences in the SF-36 domains met this threshold. However, caution is strongly advised with this arbitrary value as the clinically important within-person change varies considerably, dependent on diagnosis and duration and severity of disease, among other confounders.[@R59] Therefore, we looked for values of a clinically important within-person change in SF-36 domains following CR. On the basis that an improvement equating to half of the within-person change can be considered a worthwhile outcome for an appreciable number of people,[@R61] we set this as a criterion for a clinically important between-group difference. Usefully, for our current purpose, a heart disease expert consensus[@R62] suggested SF-36 domain-specific changes that should be considered minimal, moderate and large for an individual. Minimal changes ranged from 15 to 25 points, and moderate changes from 25 to 50 points ([online supplementary appendix 7](#SP7){ref-type="supplementary-material"}). Using this approach, the only clinically important differences in the SF-36 domains were the short-term effects on 'physical function' and 'role physical'. These are above, or close to half of, the consensus values for a moderate change. No other point estimates met the criteria for a clinically important change.

10.1136/bmjopen-2019-036089.supp7

For the MacNew Questionnaire, a within-person change of 0.5 points for any specific domain or the overall score has been proposed.[@R63] Using the same approach, we would set a between-group difference of 0.25 points as a clinically important benefit. Although none of the analyses was statistically significant, the point estimates for physical and emotional subscales and the overall score are consistent with a clinically important short-term benefit on the MacNew Questionnaire.

Strengths and limitations {#s4-1}
-------------------------

We identified 24 studies, 18 of which we could include in meta-analyses. Due to wider inclusion criteria in terms of time-points for outcome reporting, this is \>14 studies identified (8 meta-analysed) in another recent review.[@R20] Also, our search date was more recent, and we included studies testing exercise-based CR interventions in all manifestations of CAD rather than just those with acute coronary syndrome±revascularisation, angina or angiographically documented CAD. We did, however, exclude one study[@R53] from our meta-analyses that was included by the previous authors. We were unable to extract data from the line graph, and values presented in the text were not between groups differences so could not be used. We also differ from the other recent review in our interpretation of a clinically important benefit for the SF-36. This is because we used consensus values for minimal and moderate change[@R62] to define clinical importance, rather than the smallest measurable change in an SF-36 domain. We would interpret their findings as showing that there were no clinically important benefits on any SF-36 domains and that only role physical achieved a minimal benefit.

Given the heterogeneity and paucity of data included in our review, strengths and weaknesses should be considered. We performed rigorous and transparent systematic review, with meta-analysis where possible. Where there was any doubt as to data compatibility, we opted to exclude studies from the analysis, helping to ensure the integrity of the results. We included only data from studies recruiting after 31 December 1999 to ensure that findings were applicable in the era of contemporary medical care. Defining the era of contemporary medical care can be problematic due to difficulties in identifying exactly when data were collected for each trial, and the nature of medical practice at the time. Therefore, it is not possible to be certain that included and excluded trials exactly match our criteria for what constitutes contemporary medical care. However, meticulous examination of each trial provides a high level of confidence that the most appropriate studies have been included.

Our findings are limited by a number of inconsistencies in the CR literature and data. While baseline data were always collected prior to randomisation, follow-up data were reported at varying times postrandomisation. Our short-term data included studies reporting their first follow-up at anything between 1 and 6 months. Equally, our medium-term data covered studies reporting between 8 and 12 months. Data were too scarce and heterogeneous to assess time-points more accurately. It is also worth noting that only 5/24 analyses in our review included studies using CAD-specific QoL measures. It is possible that generic QoL instruments are insufficiently sensitive to detect change in people with CAD. Disease-specific tools are more likely to accurately reflect QoL in this population.

Exercise interventions and other core components of comprehensive CR varied widely in their composition and delivery, and these may have fallen short of what would be considered 'optimal' or 'gold standard' care. Equally, usual care was inconsistent which may dilute any benefit associated with exercise-based CR. Furthermore, the overall quality of studies included in our meta-analyses was poor, with the majority scoring 'some concerns' or 'high' on the risk of bias assessment. Numerous sources of potential bias were identified including poor reporting of key methodological information such as randomisation, blinding and statistical analyses.

Data reporting in some studies is a potential source of bias. First, results from one study[@R46] showed a vastly superior improvement in MacNew QoL scores compared with others[@R39] in the short-term analysis. Second, one study[@R33] reported only the total score for the SF-36 at 6 months; this is not a validated or recommended measure.[@R54] Third, for one study,[@R38] we only included n=372 (58%) participants who had IHD at 12 months follow-up, however, the SF-36 values included a proportion of participants with heart failure (12%) or at high risk of ischaemic heart disease (30%). However, this only affected the medium-term data for SF-36 MCS and PCS, as these were the only data reported in the trial. Finally, we could not perform a meta-analysis for the SF-36 PCS at 12 months in one study[@R30] as an exact p value was not provided.

Conclusions {#s5}
===========

For people with CAD participating in exercise-based CR, our meta-analyses show statistically significant improvements in multiple individual SF-36 domain scores, but only 2/24 comparisons (both short-term outcomes) can be deemed clinically important. Exercise-based CR shows promise as an approach to improve QoL for people with CAD. However, the contemporary data presented in this review are insufficient to support its routine use. Given the critical importance of QoL to people living with long-term conditions, future research should optimise CR programmes to target improvement in QoL domains.
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